Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Dudley Robert Michael
Chief Executive Officer at Transcode Therapeutics. Filing since 27 May 2022.
CIK 0001854161
Company
Date
Role
Action
Shares
Amount
Of holding
RNAZ
Transcode Therapeutics, Inc.
28 Sep 2023
Chief Executive Officer
Bought
98,000
$49.98K
119%
RNAZ
Transcode Therapeutics, Inc.
21 Jun 2023
Chief Executive Officer
Bought
12,000
$31.82K
17.1%
RNAZ
Transcode Therapeutics, Inc.
20 Jun 2023
Chief Executive Officer
Bought
6,607
$16.85K
10.4%
RNAZ
Transcode Therapeutics, Inc.
9 Jun 2023
Chief Executive Officer
Bought
19,000
$52.44K
2.1%
RNAZ
Transcode Therapeutics, Inc.
14 Sep 2022
Chief Executive Officer
Bought
20,000
$23.00K
2.3%
RNAZ
Transcode Therapeutics, Inc.
31 May 2022
Chief Executive Officer
Bought
2,000
$3.74K
0.2%
RNAZ
Transcode Therapeutics, Inc.
27 May 2022
Chief Executive Officer
Bought
28,000
$51.64K
3.3%
7 decisions on file.
